NDC 0025-2818

CALAN SR

Verapamil Hydrochloride

CALAN SR is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Verapamil Hydrochloride.

Product ID0025-2818_227045f0-f2ba-4033-ac3a-613e2e580c49
NDC0025-2818
Product TypeHuman Prescription Drug
Proprietary NameCALAN SR
Generic NameVerapamil Hydrochloride
Dosage FormTablet, Film Coated, Extended Release
Route of AdministrationORAL
Marketing Start Date2020-12-16
Marketing CategoryNDA / NDA
Application NumberNDA019152
Labeler NamePfizer Laboratories Div Pfizer Inc
Substance NameVERAPAMIL HYDROCHLORIDE
Active Ingredient Strength180 mg/1
Pharm ClassesP-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0025-2818-31

100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0025-2818-31)
Marketing Start Date2020-12-16
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "CALAN SR" or generic name "Verapamil Hydrochloride"

NDCBrand NameGeneric Name
0025-1891CALAN SRverapamil hydrochloride
0025-1901CALAN SRverapamil hydrochloride
0025-1911CALAN SRverapamil hydrochloride
0025-2712CALAN SRverapamil hydrochloride
0025-2818CALAN SRverapamil hydrochloride
0025-2924CALAN SRverapamil hydrochloride
0025-1861CALANverapamil hydrochloride
0093-3043Verapamil Hydrochlorideverapamil hydrochloride
0093-3044Verapamil Hydrochlorideverapamil hydrochloride
0093-3045Verapamil Hydrochlorideverapamil hydrochloride
0378-0512Verapamil Hydrochlorideverapamil hydrochloride

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.